See up to 3 months of ALZN. The 7-day demo opens the 1M and 3M ranges and puts ALZN on your watchlist.
Start 7-day demoLatest ALZN insider trades
Milton C. Ault III - DirectorOpen-market purchase$109K- Milton C. Ault III - DirectorOpen-market purchase
About Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. files with the SEC under CIK 0001677077 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. The registration was withdrawn on 9 October 2026, so the planned offering is not going ahead in its filed form.
ALZN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 110,388 | $111K |
| Grant or award | 9 | 1,012,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ALZN insider transactions (Form 4)
5523 Form 4 filings on record, the earliest from May 12, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Milton C. Ault III - Director | Open-market purchase | Common Stock | 108,388 | $1.00 | $109K | |
| Milton C. Ault III - Director | Open-market purchase | Common Stock | 2,000 | $1.03 footnote F2 | $2K | |
| ||||||
| Hyperscale Data, Inc. - Director | Grant or award | Series D Convertible Preferred Stock | 7,500 | $1,000.00 | $7.50M | |
| Hyperscale Data, Inc. - Director | Grant or award | Series D Convertible Preferred Stock | 7,500 | $1,000.00 | $7.50M | |
| Milton C. Ault III - Director | Grant or award | Series D Convertible Preferred Stock | 7,500 | $1,000.00 | $7.50M | |
| Henry Carl Nisser - Officer | Grant or award | Stock Options (Right to Buy) | 60,000 | $0.00 | - | |
| William B. Horne - Director | Grant or award | Stock Options (Right to Buy) | 60,000 | $0.00 | - | |
| Jeffrey Oram - Director | Grant or award | Stock Options (Right to Buy) | 60,000 | $0.00 | - | |
| Mark Gustafson - Director | Grant or award | Stock Options (Right to Buy) | 60,000 | $0.00 | - | |
| Stephan Jackman - Officer | Grant or award | Stock Options (Right to Buy) | 450,000 | $0.00 | - | |
| David J. Katzoff - Officer | Grant or award | Stock Options (Right to Buy) | 300,000 | $0.00 | - | |
| Milton C. Ault III | Open-market purchase | Common Stock | 108,388 | $1.00 | $109K | |
| Lynne Fahey McGrath | Open-market sale | Common Stock | 30 | $2.29 | $69 | |
| Milton C. Ault III | Other | Common Stock | 61,743 footnote F1 | $2.32 | $143K | |
| Milton C. Ault III | Open-market sale | Common Stock | 20,397 | $2.32 | $47K | |
| Milton C. Ault III | Open-market sale | Common Stock | 101,394 | $2.44 footnote F3 | $247K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 143.24 | $1,000.00 | $143K | |
| ||||||
| Milton C. Ault III | Other | Common Stock | 100,000 footnote F1 | $2.32 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 82,033 | $2.45 footnote F3 | $201K | |
| Milton C. Ault III | Other | Common Stock | 100,000 footnote F1 | $2.32 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 57,379 | $2.49 footnote F4 | $143K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| ||||||
| Milton C. Ault III | Open-market sale | Common Stock | 20,686 | $2.39 | $50K | |
| Milton C. Ault III | Other | Common Stock | 100,000 footnote F1 | $2.32 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 36,777 | $2.35 footnote F3 | $86K | |
| Milton C. Ault III | Open-market sale | Common Stock | 65,903 | $2.44 footnote F4 | $161K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| ||||||
| Milton C. Ault III | Open-market sale | Common Stock | 37,738 | $2.31 | $87K | |
| Milton C. Ault III | Open-market sale | Common Stock | 38,324 | $2.31 | $88K | |
| Milton C. Ault III | Open-market sale | Common Stock | 3,566 | $2.33 | $8K | |
| Milton C. Ault III | Open-market sale | Common Stock | 43,238 | $2.38 | $103K | |
| Milton C. Ault III | Open-market sale | Common Stock | 39,140 | $2.31 | $90K | |
| Milton C. Ault III | Open-market sale | Common Stock | 14,628 | $2.31 | $34K | |
| Milton C. Ault III | Other | Common Stock | 100,000 | $2.32 | $232K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 77,009 | $2.35 | $181K | |
| Milton C. Ault III | Other | Common Stock | 100,000 | $2.32 | $232K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| Milton C. Ault III | Other | Common Stock | 100,000 | $2.32 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 2,121 | $2.45 | $5K | |
| Milton C. Ault III | Open-market sale | Common Stock | 20,870 | $2.47 | $51K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| Milton C. Ault III | Other | Common Stock | 100,000 | $2.32 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 29,449 | $2.51 | $74K | |
| Milton C. Ault III | Open-market sale | Common Stock | 100,000 | $2.22 | $222K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 232 | $1,000.00 | $232K | |
| Milton C. Ault III | Open-market sale | Common Stock | 36,532 | $2.90 | $106K | |
| Milton C. Ault III | Open-market sale | Common Stock | 8,311 | $2.68 | $22K | |
| Milton C. Ault III | Other | Common Stock | 143,429 | $2.32 | $333K | |
| Milton C. Ault III | Open-market sale | Common Stock | 59,516 | $2.95 | $176K | |
| Milton C. Ault III | Open-market sale | Common Stock | 9,621 | $2.93 | $28K | |
| Milton C. Ault III | Other | Series B Convertible Preferred Stock | 332.76 | $1,000.00 | $333K | |
| Milton C. Ault III | Open-market sale | Common Stock | 1,213 | $5.06 | $6K | |
| Milton C. Ault III | Open-market sale | Common Stock | 11 | $5.28 | $58 | |
Item 7.01, 9.01
Item 1.01, 3.01, 3.02, 5.03, 9.01
Item 8.01, 9.01
Item 5.07, 9.01
ALZN insider trading FAQ
What is the latest insider trade for ALZN?
Alzamend Neuro, Inc. (ALZN) had 10 insider filings in the last 90 days, with the most recent on 2026-08-31. The full record for ALZN runs to 23 Form 4 filings, the earliest from 2025-05-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ALZN stock?
2 insider purchases of ALZN were filed in the last 90 days, totaling $111K.
How many insiders are selling ALZN stock?
No insider sales of ALZN were filed in the last 90 days. 25 sales are on record for this company.
Where can I see ALZN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ALZN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Milton C. Ault III view on EDGAR
- - Hyperscale Data, Inc. view on EDGAR
- - Hyperscale Data, Inc. view on EDGAR
- - Milton C. Ault III view on EDGAR
- - Henry Carl Nisser view on EDGAR
- - William B. Horne view on EDGAR
- - Jeffrey Oram view on EDGAR
- - Mark Gustafson view on EDGAR
- - Stephan Jackman view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where ALZN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ALZN with a 7-day demo
- ALZN on your watchlist
- Every ALZN Form 4 filing on record
- Up to 3 months of ALZN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
